Replay available

Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call

Quest Diagnostics Incorporated (NYSE: DGX) Q3 2025 earnings conference call, held 2025-10-21. Replay captured from the company's public earnings webcast.

Tue, October 21, 2025 at 8:30 AMendedReplay
Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call

Hosted by

Featured presenters

Jim Davis

President and Chief Executive Officer, Quest Diagnostics

Patrick Donnelly

Analyst, Citi

Michael Turney

Analyst, Lyric Partners

Elizabeth Anderson

Analyst, Evercore ISI

Kevin Caliendo

Analyst, UBS

Jack Mann

Analyst, Nefron Research

David Westenberg

Analyst, Piper Sandler

Michael Riskin

Analyst, Bank of America

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Quest Diagnostics Incorporated.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.135 Growth rates associated with our long-term outlook projections, including consolidated 00:00:04.135 -- 00:00:08.779 revenue growth, revenue growth from acquisitions, organic revenue growth, and adjusted 00:00:08.779 -- 00:00:11.842 earnings growth, are compound annual growth rates. 00:00:11.842 -- 00:00:14.665 Now, here is Jim Davis. 00:00:14.665 -- 00:00:19.690 Thanks, Sean, and good morning, everyone. Our third quarter performance underscores 00:00:19.690 -- 00:00:25.235 strong demand for our clinical solutions, our diligent execution to meet customer needs, 00:00:25.235 -- 00:00:28.212 and our commitment to advancing our strategy. 00:00:28.212 -- 00:00:33.220 We delivered robust top and bottom line growth, extended our presence in key 00:00:33.220 -- 00:00:38.648 markets, forged new collaborations with leaders across healthcare, and expanded 00:00:38.648 -- 00:00:44.337 our broad portfolio of diagnostic innovations to advance better health. 00:00:44.337 -- 00:00:47.381 Revenues grew 13.1%, including 00:00:47.381 -- 00:00:49.304 6.8% organic 00:00:49.304 -- 00:00:54.612 growth, driven by broad-based adoption of our clinical innovations, contributions 00:00:54.612 -- 00:00:59.672 from acquisitions, and growth in our consumer channel as we position Quest as 00:00:59.672 -- 00:01:04.237 the preferred lab engine inside top wellness brands. 00:01:04.237 -- 00:01:09.324 We also announced an agreement with Corwell Health to form a lab services joint venture 00:01:09.324 -- 00:01:14.510 serving the state of Michigan. In addition, we will deploy our comprehensive 00:01:14.510 -- 00:01:19.617 CoLab solutions across Corwell's nearly two dozen hospitals, supporting 00:01:19.617 -- 00:01:24.760 quality, innovation, access, and productivity. 0...